Effects of onceweekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity
If you are nursing and considering semaglutide, the injectable form is the appropriate choice
This curve exists because: Appetite resets at a lower level Your baseline hunger is suppressed, but your body recalibrates its energy balance signals Resting metabolic rate decreases A lighter body burns fewer calories at rest, even without any change in habits Muscle mass may decline Without adequate protein and resistance exercise, up to 40% of weight lost can come from lean tissue, further suppressing metabolism Dose ceiling effects emerge Many patients on a stable dose reach the therapeutic maximum for their current titration level "A GLP-1 plateau is your body asking for a more complete strategy not a sign that treatment has failed
Convenient Once-Weekly Dosing: Administered through a simple once-weekly injection, semaglutide fits easily into busy lifestyles, enhancing adherence and consistency
BP drops faster than weight loss alone would predict, sometimes to 100/60 or lower, with orthostatic symptoms
Weight loss in the PTU-treated group indicates that the well-known weight gaining effect of hypothyroidism requires longer period to occur